Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
841.5000
-12.30
(
-1.44
%)
NSE
Aug 31, 2026
15:31 PM
31.41% Fall from 52W High
Volume:
412.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
27 Mar 2024
841.50
-1.44%
NATCO PHARMA
Accumulate:
Natco Pharma Ltd.
by
Geojit BNP Paribas
Target: 1116
Recommendation
Target
Geojit BNP Paribas
Natco Pharma Ltd. is trading below all available SMAs
More from Natco Pharma Ltd.
Recommended
IPO market starts September with a packed listing calendar
|
31 Aug 2026, 05:00PM
Market closes lower as oil prices cross $90 per barrel following US-Iran strikes
Trendlyne Marketwatch |
31 Aug 2026, 04:02PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020